Clinical Trial Update: Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial investigated metformin as preventive treatment for paclitaxel-induced peripheral neuropathy in breast cancer patients; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Peripheral Neuropathy

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Mansoura University | Conditions: Peripheral Neuropathy, Breast Cancer | Phase 2 | Status: COMPLETED